6Fagniez P L,Yahchouchy E.Use of somatostatin in the treatment of digestive fistulas.Pharmacoeconomic issues[J].Digestion,1999,60(Suppl 3):65-70.
7Shimoda N,Tashiro T,Yamamori H,et al.Effects of growth hormone and insulin-like growth foctor-1 on protein metabolism,gut morphology,and cell-mediated immunity in burned rats[J].Nutrition,1997,13(6):540-546.
2[1]Napolitano LM, Ferrer T, McCarter RJ Jr, et al. Systemic inflammatory response syndrome score at admission independently predicts mortality and length of stay in trauma patients. J Trauma,2000,49(4):647
3[3]Swank GM, Deitch EA. Role of the gut in multiple organ failure: bacterial translocation and permeability changes. World J Surg, 1996,20(5):411
4[1]Dardai E,Pirtyi S,Nagy L.Parental and enteral nutrition and the enterocutaneous fistula treatment.Ⅱ.factors influencing the outcome of treatment[J].Acta Chir Hung,1991,32(4):305.
5[2]Archer SR,Bumetl RJ,Fischer JE.Current uses and abuses of total parenteral nutrition[J].Adv Surg,1996,29:165.
6[3]Tassiopoulos AK,Baum G,Halverson JD.Small bowel fistulas[J].Surg Clin North Am,1996,76(5):1175.
7[4]Meguid MM,Camois AC.Nutritional management of patients with gastrointestinal fistulas[J].Surg Clin North Am,1996,76(5):1035.
8[5]Cresci GA,Martindale RG.Metabolic and nutritional management of a patient with multiple enterocutaneous fistulas[J].Nutrition,1997,13(5):446.
9[6]Walters G,Kahn A,Jescovitch AJ.Efficacy of a central venous access service[J].South Med J,1997,90(1):37.
10[7]Martnez D,Zibari G,Aultman D.The outcome of intestinal fistulae:the Louisiana State University Medical Center-Shreveport experience[J].Am Srg,1998,64(3):252.
